2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Cancer: Breakthrough Pain
1
Interventions
Morphine
1
Ketamine
1
Chitosan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer: Breakthrough Pain
×
Chitosan
×
Clear all
NCT02591017
2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3
Terminated
11 enrolled